SCHEMBL11297505

SCHEMBL11297505

N#Cc1cccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 7/20 0.37
▸ HDAC6 Q9UBN7 6/20 0.37
▸ HDAC1 Q13547 5/20 0.37
▸ KMT2A Q03164 1/20 0.35
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ SMPD1 P17405 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MEP1A Q16819 1/20 0.34
▸ MEP1B Q16820 1/20 0.34
▸ GRM5 P41594 3/20 0.34
▸ MAPKAPK2 P49137 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296049 0.89 HDAC6 (0.45) HDAC8HDAC6HDAC1KMT2ASMPD1
SCHEMBL11298752 0.85 HDAC8 (0.42) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11302647 0.85 HDAC6 (0.43) HDAC8HDAC6HDAC1KMT2ANPC1
SCHEMBL11296174 0.84 HDAC8 (0.44) HDAC8HDAC6HDAC1KMT2ANPC1
SCHEMBL11300469 0.83 HDAC6 (0.47) HDAC8HDAC6HDAC1KMT2A
SCHEMBL11297424 0.82 HDAC1 (0.43) HDAC8HDAC6HDAC1NPC1RAB9A
SCHEMBL11301397 0.82 HDAC1 (0.39) HDAC8HDAC6HDAC1
SCHEMBL11304336 0.82 HDAC6 (0.42) HDAC8HDAC6HDAC1
SCHEMBL11301404 0.82 HDAC8 (0.47) HDAC8HDAC6HDAC1KMT2ANPC1
SCHEMBL11297369 0.81 HDAC6 (0.40) HDAC8HDAC6HDAC1KMT2AMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback